Clinical Trials Browser

Completed × INDUSTRY × tasquinimod × Clear all

NCT01743469 2019-01-08

A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers

Phase 2 Completed

201 enrolled 23 charts

GastrointestinalGenitourinaryGynecologic

Carcinoma, Renal Cell, Liver Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Stomach Neoplasms

NCT00560482 2015-10-26

Efficacy Study of ABR-215050 to Treat Prostate Cancer

Phase 2 Completed

Neoplasms, Prostatic Neoplasms

NCT01234311 2015-10-21

A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms